Primary record
1H-PYRROLE-1-HEPTANOIC ACID, 2-(4-FLUOROPHENYL)-.BETA.,.DELTA.-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-((PHENYLAMINO)CARBONYL)-, (.BETA.R,.DELTA.R)-REL-
- 库存
- 1,365 克
- 纯度
- 99.5 %
- CAS
- 501121-34-2
化合物标识与属性
- CAS
- 501121-34-2
- PubChem CID
- 62976
- SMILES
- CC(C)C1=C(C(=C(N1CC[C@@H](C[C@@H](CC(=O)O)O)O)C2=CC=C(C=C2)F)C3=CC=CC=C3)C(=O)NC4=CC=CC=C4
- Canonical SMILES
- CC(C)c1c(C(=O)Nc2ccccc2)c(-c2ccccc2)c(-c2ccc(F)cc2)n1CC[C@H](O)C[C@H](O)CC(=O)O
名称与同义词
- ent-Atorvastatin
- atorvastatin
- (3S,5S)-Atorvastatin
- S,S-ATORVASTATIN
- 3S,5S-Atorvastatin
- Lipitor
- .atorvastatin
- Sotis
- (rel)-Atorvastatin
- Atorvastatin, (+/-)-
- Atorvastatin lysine
- 501121-34-2
- Atorvastatin EP Impurity E
- Atorvastatin impurity E
- Atorvastatin, (RS)-
- (3r,5r)-atorvastatin
- U2H272PQ8B
- UNII-36TN91XZ0V
- UNII-U2H272PQ8B
- RefChem:1084110
- (3S,5S)-Atorvastatinent
- Atorvastatin, Calcium salt
- Atorvastatin Impurity 153
- C33H35FN2O5
- AC1L1Y5A
- AC1Q5T2U
- 36TN91XZ0V
- Atorvastatin, (3RS,5RS)-
- DTXSID70861327
- orb1705249
- SCHEMBL13900412
- HY-B0589C
- DTXSID60274003
- MFCD09839951
- DTXCID201781364
- 110862-48-1
- CID62976
- C33-H35-F-N2-O5
- CI 981
- CI-981
- EBC-46270
- EX-A14962
- ZINC11615928
- AKOS030531929
- Atorvastatin EP Impurity E (Free Base)
- AN-33624
- DA-59649
- DA-69093
- MS-30164
- Atorvastatin calcium trihydrate impurity E [EP]
- LS-172139
- CS-0108991
- J3.077.142G
- G13603
- (3s,5s)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1h-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid
- EN300-2010625
- A899726
- (3S,5S)-7-(2-(4-Fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid
- ATORVASTATIN CALCIUM IMPURITY E [EP IMPURITY]
- (1betaR,deltaR)-2-(p-Fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoic acid
- (3S,5S)-7-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid
- 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-, (betaR,deltaR)-rel-
- (3S,5S)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid
- 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-, (betaS,deltaS)-
- 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-, (R*,R*)-
- Atorvastatin EP Impurity E; USP Atorvastatin Related Compound E
- (3S,5S)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid
- (3S,5S)-3,5-Dihydroxy-7-[2-isopropyl-3-(phenylcarbamoyl)-4-phenyl-5-(4-fluorophenyl)-1-pyrrolyl]heptanoic acid
- (3S,5S)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid
- (betaS,deltaS)-2-(4-Fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid
- 1H-PYRROLE-1-HEPTANOIC ACID, 2-(4-FLUOROPHENYL)-.BETA.,.DELTA.-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-((PHENYLAMINO)CARBONYL)-
- 1H-PYRROLE-1-HEPTANOIC ACID, 2-(4-FLUOROPHENYL)-.BETA.,.DELTA.-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-((PHENYLAMINO)CARBONYL)-, (.BETA.R,.DELTA.R)-REL-
- 1H-PYRROLE-1-HEPTANOIC ACID, 2-(4-FLUOROPHENYL)-.BETA.,.DELTA.-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-((PHENYLAMINO)CARBONYL)-, (R*,R*)-
- 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-|A,|A-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, (|AR,|AR)-rel-
- 1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-, (betaS,deltaS)-
- rel-(3S,5S)-7-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid